Both immunisation with a formalin-inactivated respiratory syncytial virus (RSV) vaccine and a mock antigen vaccine induce severe lung pathology and a Th2 cytokine profile in RSV-challenged mice

Vaccine

Volumn 19, Issue 7-8, 2000, Pages 982-991

  Boelen, Anita ^a   Andeweg, Arno ^b   Kwakkel, Joan ^a   Lokhorst, Wil ^a   Bestebroer, Theo ^b   Dormans, Jan ^a   Kimman, Tjeerd ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

FI RSV vaccination; RSV; Th2 response

Indexed keywords

VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRONCHOPNEUMONIA; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HISTOPATHOLOGY; INFLAMMATION; LUNG DISEASE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VACCINATION; VIRUS REPLICATION;

ANIMALS; ANTIBODIES, VIRAL; CHILD, PRESCHOOL; CYTOKINES; FEMALE; FORMALDEHYDE; HUMANS; IMMUNIZATION; INFANT; INFLAMMATION; LUNG; MICE; MICE, INBRED BALB C; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; RNA, MESSENGER; TH1 CELLS; TH2 CELLS; VACCINES, INACTIVATED; VIRAL VACCINES; VIRUS REPLICATION;

EID: 0034703854     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00213-9     Document Type: Article

References (27)

1. Respiratory syncytial virus
2. Economic impact of viral respiratory disease in children
3. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective study with matched controls
4. Formalin-inactivated respiratory syncytial virus vaccine induces antibodies to the fusion glycoprotein that are deficient in fusion-inhibiting activity
5. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine
6. Priming immunisation determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus
7. Th1 and Th2 cytokine induction in pulmonary T-cells during infection with respiratory syncytial virus
8. Analysis of the local and systemic immune responses induced in BALB/c mice by experimental respiratory syncytial virus infection
9. Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunised BALB/c mice is abrogated by depletion of CD4+ cells
10. Respiratory syncytial virus G and/or SH protein alters Th1 cytokines natural killer cells, and neutrophils responding to pulmonary infection in BALB/c mice
11. Mechanism of lung injury in cotton rats immunized with formalin-inactivated respiratory syncytial virus
12. Enhanced pulmonary pathology associated with the use of formalin-inactivated respiratory syncytial virus vaccine in cotton rats is not a unique viral phenomenon
13. Respiratory syncytial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induced enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern
14. Review of polyclonal antibody production procedures in mammals and poultry
15. Adjuvants influence the quantitative and qualitative immune response in BALB/c mice immunized with respiratory syncytial virus FG subunit vaccine
16. Rapid detection of respiratory syncytial virus and influenza A virus in cell cultures by immunoperoxidase staining with monoclonal antibodies
17. Single-step method of RNA isolation by acid guanidium thiocynate-phenol chloroform extraction
18. Standardisation of mRNA titration using a polymerase chain reaction method involving co-amplification with a multispecific internal control
19. Intracellular IFN-γ expression in natural killer cells precedes lung CD8+T-cell recruitment during respiratory syncytial virus infection
20. Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactivated virus
21. Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10
22. Pathogenesis of respiratory syncytial virus vaccine-augmented pathology
23. Distinct types of lung disease caused by functional subsets of antiviral T-cells
24. Regulation of cytokine expression by adjuvants in vivo
25. Priming with live respiratory syncytial virus (RSV) prevents the enhanced pulmonary inflammatory response seen after RSV challenge in BALB/c mice immunized with formalin-inactivated RSV
26. Development of allergen-specific T-cell memory in atopic and normal children
27. Respiratory syncytial virus infection prolongs methacholine-induced airway hyperresponsiveness in ovalbumin-sensitized mice